Our Company

The Best Human Platelet Lysates. The Longest Clinical Experience.

Innovative Approaches

Mill Creek Life Sciences provides the tools and technologies to support the development and application of cellular and biologic therapeutics. Mill Creek Life Sciences technology was licensed from discoveries at the Mayo Clinic. We are committed to discovering and applying innovative approaches to cellular therapy and patient care.


Mill Creek Life Sciences was founded with a singular purpose in mind: to bring new solutions to accelerate cellular therapies for patients. For us it is about quality, innovation and customer service. We work closely with our customers, helping fulfil their needs and supporting them through analyzing and troubleshooting specific applications when needed.

mirsch cover photo



William Mirsch

Chief Executive Officer
Read Full Bio

Dr. Vanesa Alonso-Camino

Principal Scientist
Read Full Bio

Lisa Carey

Senior Quality Manager
Read Full Bio

Jessica Vanderwielen

Senior Production Manager
Read Full Bio

Jeff Nielsen

Business Development Manager
Read Full Bio

Dr. Allan Dietz

Founder and Scientific Advisor
Read Full Bio
Daryl Headshot

Daryl McLinden

Fractional Chief Financial Officer
Read Full Bio


Mill Creek Life Sciences was founded in 2010 by Dr. Allan Dietz, then director of the Human Cellular Therapy Laboratory at the Mayo Clinic in Rochester, MN. Dr. Dietz’s lab developed a process to turn outdated human platelets into human platelet lysate (hPL), as a substitute for calf serum. This technology was licensed to MCLS, which was the first company to commercially sell human platelet lysate.

History Timeline